Duearity AB has entered into an agreement with a distributor in Great Britain. The goal is to sell more than a couple of thousand Tinearity G1 start kits in the UK per year after full launch and then increase the sales. The agreement is Duearity's second distributor agreement, and the company is expected to enter into more distributor agreements and agreements with clinics in Europe and the US during 2023.

The distributor has carried out a solid analysis of Tinearity G1's conditions in Great Britain, through contacts with expertise in the field of tinnitus. The distributor agreement is implemented immediately and the marketing and sales in the UK start in August this year. According to the distributor, a reasonable goal is to selling more than a couple of thousand tinearity G1 starter kits per year after full launch and then increase sales.

Following approval by the NHS in Great Britain, the aim is to sell more than 5,000 Tinearity G1 starter kit per year. The distributor intends to initiate a pilot study which will be used for the purpose of Tinearity G1 being approved by the NHS, the British subsidy system. Tinearity G1 is expected to be approved by the NHS in 2024.

The distributor company, Prime Health Distribution Ltd, which is owned by Marta Neto and Phil Bradshaw, has been active in the ear and hearing field for 30 years and has a very large network of contacts among clinics, doctors, audiologists and the British patient organization British Tinnitus. The distributor company will focus solely on the marketing and sales of Tinearity G1. The agreement is DuearITY's second distributor agreement, and will enter into more agreements in Europe and USA during 2023.